The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AKTIS ONCOLOGY INC COM 01021M104 17,046,379 952,844 SH DFND 0 952,844 0
ALECTOR INC COM 014442107 7,623,297 3,545,719 SH DFND 0 3,545,719 0
CARISMA THERAPEUTICS INC COM 14216R101 47,880 1,473,240 SH DFND 0 1,473,240 0
EIKON THERAPEUTICS INC COM 282564103 17,633,326 1,666,666 SH DFND 0 1,666,666 0
ENTRADA THERAPEUTICS INC COM 29384C908 21,955,872 1,739,768 SH DFND 0 1,739,768 0
EVAXION BIOTECH A/S SPONSORED ADS 29970R204 4,516,549 1,214,126 SH DFND 0 1,214,126 0
KYMERA THERAPEUTICS INC COM 501575104 64,313,623 772,165 SH DFND 0 772,165 0
MODERNA INC COM 60770K107 117,256,052 2,308,190 SH DFND 1 0 2,308,190 0
NEUPHORIA THERAPEUTICS INC COM 64136E102 40,810 10,027 SH DFND 1 0 10,027 0
PERSONALIS INC COM 71535D106 89,466,287 14,044,943 SH DFND 1 0 14,044,943 0
SUTRO BIOPHARMA INC COM 869367102 6,784,263 272,351 SH DFND 1 0 272,351 0
TUHURA BIOSCIENCES COM 898920103 34,807 19,445 SH DFND 1 0 19,445 0
VIRIDIAN THERAPEUTICS INC COM 92790C104 1,827,178 93,414 SH DFND 0 93,414 0
XILIO THERAPEUTICS INC COM 98422T209 891,309 105,982 SH DFND 0 105,982 0